Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


NGM Biopharmaceuticals Q2 EPS $(0.38) Down From $(0.13) YoY, Sales $19.75M Down From $25.34M YoY


Benzinga | Aug 12, 2020 04:20PM EDT

NGM Biopharmaceuticals Q2 EPS $(0.38) Down From $(0.13) YoY, Sales $19.75M Down From $25.34M YoY

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.38) per share. This is a 192.31 percent decrease over losses of $(0.13) per share from the same period last year. The company reported $19.75 million in sales this quarter. This is a 22.04 percent decrease over sales of $25.34 million the same period last year.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC